LYVE1 and neoplasm: In summary, both tissue-based immune cells and metastatic tumours employ similar adhesive interactions between their endogenous HA surface glycocalyx and the endothelial receptor LYVE-1 to enter afferent lymphatics and migrate to downstream lymph nodes - the former to promote immunity and its resolution and the latter for systemic dissemination (Fig. 1).